CI Investments Inc
APLS

CI Investments Inc’s Apellis Pharmaceuticals APLS Stock Holding History

CI Investments Inc’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-165
Closed -$5K – 1304
2024
Q3 		$5K Sell
165
-2,444
-94% -$90.5K ﹤0.01% 1246
2024
Q2 		$100K Sell
2,609
-223
-8% -$10.1K ﹤0.01% 815
2024
Q1 		$166K Buy
2,832
+2,684
+1,814% +$171K ﹤0.01% 756
2023
Q4 		$9K Sell
148
-1,593
-91% -$80.8K ﹤0.01% 1167
2023
Q3 		$66K Sell
1,741
-248
-12% -$10.9K ﹤0.01% 909
2023
Q2 		$181K Buy
1,989
+1,164
+141% +$100K ﹤0.01% 654
2023
Q1 		$54K Buy
825
+686
+494% +$39.6K ﹤0.01% 881
2022
Q4 		$7K Buy
+139
New +$7.37K ﹤0.01% 1149

Other funds holding APLS

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

CI Investments Inc's APLS Position: Q4 2024 in Review

CI Investments Inc sold out of Apellis Pharmaceuticals (APLS) in Q4 2024, closing a stake of 165 shares — an estimated $5K sold.

CI Investments Inc first reported a position in APLS in Q4 2022 and held it in 8 quarters. The position peaked at $181K in Q2 2023. 260 funds tracked by Wall St. Rank hold APLS as of Q4 2024.

  • CI Investments Inc reported no remaining Apellis Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • CI Investments Inc sold 165 Apellis Pharmaceuticals shares in Q4 2024, an estimated $5K.
  • CI Investments Inc first reported a position in Apellis Pharmaceuticals in Q4 2022 and held it in 8 quarters.
  • CI Investments Inc's Apellis Pharmaceuticals position peaked at $181K in Q2 2023.
  • 260 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q4 2024.

Based on CI Investments Inc's 13F filing for Q4 2024, filed 12 Feb 2025.